MiniMed Group, Inc. Common Stock
MMED
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.5B
Close$
$44.83
123.9% upside
Current Fair Value
123.9% upsideUndervalued by 123.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.50 Billion |
|---|---|
| Enterprise Value | $5.40 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.29 |
| Beta | -3.68 |
| Outstanding Shares | 268,100,000 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -17.82 |
|---|---|
| PEG | 143.23 |
| Price to Sales | - |
| Price to Book Ratio | 1.54 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-0.15
Average shareholder expectationRevenue Estimate
$828.61 M
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$0.10
Average shareholder expectationRevenue Estimate
$827.70 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 4.55%▼ 8.10% |
|---|---|
| Total Invested | $182.47M▼ 62.33% |
| Investors Holding | 26▼ 34.00% |
ESG Score
No data
About MiniMed Group, Inc. Common Stock
CEO: Que Thanh Dallara MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion s...